|Description||Cholesterol measurment used in screening or patient monitoring.|
|Indication||Lipid screening, cardiovascular disease, family history, presence of xanthoma, xanthelasma, obesity, DM or gout.
|Interpretation||Cholesterol levels should be assesed in relation to other risk factors using the risk tables. Exclude secondary causes of hyperlipidaemia such as hypothyroidism, cholestasis, nephrotic syndrome, diabetes mellitus. If cholesterol is <5.2 mmol/L reasses in 10 yrs. If cholesterol is >6.5 mmol/L obtain fasting sample and measure full lipid profile. Cholesterol of 8 - 15 mmol/L is indicative of heterozygous FH and >15 mmol/L is indicative of homozygous FH.
|Tube||Serum or Heparin|
|Collection Conditions||Overnight fast if for lipid profile analysis.|
|Min. Vol||1 mL|
|Ref. Range (Male)||2.6 - 5.2|
|Ref. Range (Female)|| |
|Ref. Range (Paed)|| |
|Ref. Range Notes||
|IP Acute TAT||Refer to Website|
|IP Routine TAT||Refer to Website|
|GP Acute TAT||- Contact Laboratory|
|GP Routine TAT||Refer to Website|
|Turnround Comment||Minimum re-test interval = 28 days|
Originally edited by : JHB. Review due on 04/12/2015 16:13:00. Published By Sylvia Bennett on 04/12/2014 16:13:00.